Literature DB >> 17437544

Transcriptome analysis reveals altered cholesterol metabolism during the neurodegeneration in mouse scrapie model.

Wei Xiang1, Manuela Hummel, Gerda Mitteregger, Claudia Pace, Otto Windl, Ulrich Mansmann, Hans A Kretzschmar.   

Abstract

To identify the dynamic transcriptional alterations in CNS during the development of prion disease, brains of scrapie-infected mice and age-matched, mock-inoculated controls were analyzed immediately before inoculation and at different time points post-inoculation using Affymetrix microarray technique. A total of 449 probe sets, representing 430 genes, showed differential expression between scrapie- and mock-inoculated mice over the time course. These genes could be separated into two clusters according to expression patterns: the genes in cluster 1 demonstrated lower mRNA levels in scrapie-infected brains when compared with mock-inoculated brains, whereas genes in cluster 2 showed higher mRNA levels in scrapie-infected brains. Functional analysis of differentially expressed genes revealed the most severely affected biological process: cholesterol metabolism. The expression patterns of the cholesterol-related genes indicated an inhibited cholesterol synthesis in the diseased brains. Conspicuously, a number of cluster 1 genes, including some of cholesterol-related genes, showed not only decreasing mRNA levels in scrapie-infected brains but also increasing mRNA levels in mock-inoculated brains with increasing age. Quantitative RT-PCR analysis of some cholesterol-related genes in untreated mice suggested that changes of the examined genes observed in mock-inoculated brains are mainly age related. This finding indicated a link between age-related genes and scrapie-associated neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17437544     DOI: 10.1111/j.1471-4159.2007.04566.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  29 in total

1.  Infrared microspectroscopy: a multiple-screening platform for investigating single-cell biochemical perturbations upon prion infection.

Authors:  Alessandro Didonna; Lisa Vaccari; Alpan Bek; Giuseppe Legname
Journal:  ACS Chem Neurosci       Date:  2011-01-11       Impact factor: 4.418

2.  Glycosylation-related genes are variably expressed depending on the differentiation state of a bioaminergic neuronal cell line: implication for the cellular prion protein.

Authors:  Myriam Ermonval; Daniel Petit; Aurélien Le Duc; Odile Kellermann; Paul-François Gallet
Journal:  Glycoconj J       Date:  2008-10-21       Impact factor: 2.916

3.  Upregulation of interferon-gamma-induced genes during prion infection.

Authors:  Laura R Moody; Allen J Herbst; Judd M Aiken
Journal:  J Toxicol Environ Health A       Date:  2011

4.  The Prion Disease Database: a comprehensive transcriptome resource for systems biology research in prion diseases.

Authors:  Nils Gehlenborg; Daehee Hwang; Inyoul Y Lee; Hyuntae Yoo; David Baxter; Brianne Petritis; Rose Pitstick; Bruz Marzolf; Stephen J Dearmond; George A Carlson; Leroy Hood
Journal:  Database (Oxford)       Date:  2009-09-17       Impact factor: 3.451

5.  Identification and structural analysis of C-terminally truncated collapsin response mediator protein-2 in a murine model of prion diseases.

Authors:  Fumiko Shinkai-Ouchi; Yoshio Yamakawa; Hideyuki Hara; Minoru Tobiume; Masahiro Nishijima; Kentaro Hanada; Ken'ichi Hagiwara
Journal:  Proteome Sci       Date:  2010-10-20       Impact factor: 2.480

6.  Comparative prion disease gene expression profiling using the prion disease mimetic, cuprizone.

Authors:  Laura R Moody; Allen J Herbst; Han Sang Yoo; Joshua P Vanderloo; Judd M Aiken
Journal:  Prion       Date:  2009-04-19       Impact factor: 3.931

7.  Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease.

Authors:  Anna Bartoletti-Stella; Patrizia Corrado; Nicola Mometto; Simone Baiardi; Pascal F Durrenberger; Thomas Arzberger; Richard Reynolds; Hans Kretzschmar; Sabina Capellari; Piero Parchi
Journal:  Mol Neurobiol       Date:  2018-11-16       Impact factor: 5.590

8.  Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells.

Authors:  Rajeev Kumar; Denise McClain; Rebecca Young; George A Carlson
Journal:  J Gen Virol       Date:  2008-06       Impact factor: 3.891

9.  Dendritic pathology in prion disease starts at the synaptic spine.

Authors:  Martin Fuhrmann; Gerda Mitteregger; Hans Kretzschmar; Jochen Herms
Journal:  J Neurosci       Date:  2007-06-06       Impact factor: 6.167

10.  Transcriptional changes in the brains of cattle orally infected with the bovine spongiform encephalopathy agent precede detection of infectivity.

Authors:  Yue Tang; Wei Xiang; Steve A C Hawkins; Hans A Kretzschmar; Otto Windl
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.